Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,000 | 20,900 | 84,900 | 89,500 | 95,100 |
| Receivables | 906,100 | 952,100 | 894,500 | 988,900 | 922,800 |
| Inventories | 1,086,300 | 1,079,200 | 1,113,400 | 1,087,300 | 1,099,100 |
| Other current assets | 203,000 | 212,300 | 239,300 | 234,400 | 237,300 |
| TOTAL | $2,242,400 | $2,264,500 | $2,332,100 | $2,400,100 | $2,354,300 |
| Non-Current Assets | |||||
| PPE Net | 1,196,800 | 1,205,100 | 1,164,800 | 1,171,000 | 1,169,400 |
| Intangibles | 1,976,200 | 1,989,400 | 2,516,600 | 2,537,800 | 2,565,000 |
| Other Non-Current Assets | 317,300 | 305,100 | 333,700 | 339,100 | 344,400 |
| TOTAL | $3,490,300 | $3,499,600 | $4,015,100 | $4,047,900 | $4,078,800 |
| Total Assets | $5,732,700 | $5,764,100 | $6,347,200 | $6,448,000 | $6,433,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,400 | 12,400 | 12,500 | 7,700 | 2,300 |
| Accounts payable and accrued liabilities | 258,800 | 291,800 | 246,100 | 256,800 | 270,600 |
| Accrued Expenses | 434,400 | 554,800 | 618,100 | 567,500 | 512,600 |
| TOTAL | $2,012,600 | $2,039,900 | $2,161,400 | $2,183,500 | $2,158,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,151,600 | 1,151,800 | 1,152,500 | 1,157,400 | 1,163,600 |
| aiOther Non-Current Liabilities | 379,900 | 381,600 | 392,700 | 409,100 | 417,700 |
| TOTAL | $1,589,500 | $1,588,300 | $1,607,300 | $1,624,200 | $1,635,800 |
| Total Liabilities | $3,602,100 | $3,628,200 | $3,768,700 | $3,807,700 | $3,794,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,846 | 153,760 | 154,692 | 156,914 | 158,328 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 3,944,100 | 3,919,700 | 4,292,100 | 4,292,700 | 4,231,900 |
| Other shareholders' equity | -103,000 | -70,100 | -76,200 | -57,400 | -27,400 |
| TOTAL | $2,130,600 | $2,135,900 | $2,578,500 | $2,640,300 | $2,638,700 |
| Total Liabilities And Equity | $5,732,700 | $5,764,100 | $6,347,200 | $6,448,000 | $6,433,100 |